Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway

Basic and Clinical Pharmacology and Toxicology

Volumn 102, Issue 6, 2008, Pages 543-551

  Okano, Jun Ichi ^a   Nagahara, Takakazu ^a   Matsumoto, Kazuya ^a   Murawaki, Yoshikazu ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CAFFEINE; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; LIVER NEOPLASMS; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 43749102686     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2008.00231.x     Document Type: Article

References (27)

1. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999 19 : 271 85.
2. Okuda H. Hepatocellular carcinoma development in cirrhosis. Best Pract Res Clin Gastroenterol 2007 21 : 161 73.
3. Bode AM, Dong Z. The enigmatic effects of caffeine in cell cycle and cancer. Cancer Lett 2007 247 : 26 39.
4. Ruhl CE, Everhart JE. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 2005 129 : 1928 36.
5. Gallus S, Bertuzzi M, Tavani A, Bosetti C, Negri E, La Vecchia C et al. Does coffee protect against hepatocellular carcinoma? Br J Cancer 2002 87 : 956 9.
6. Gelatti U, Covolo L, Franceschini M, Pirali F, Tagger A, Ribero ML et al. Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study. J Hepatol 2005 42 : 528 34.
7. Kurozawa Y, Ogimoto I, Shibata A, Nose T, Yoshimura T, Suzuki H et al. Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer 2005 93 : 607 10.
8. Ohfuji S, Fukushima W, Tanaka T, Habu D, Tamori A, Sakaguchi H et al. Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: A case-control study. Hepatol Res 2006 36 : 201 8.
9. Shimazu T, Tsubono Y, Kuriyama S, Ohmori K, Koizumi Y, Nishino Y et al. Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan. Int J Cancer 2005 116 : 150 4.
10. Balansky RM, Blagoeva PM, Mircheva ZI, De Flora S. Modulation of diethylnitrosamine carcinogenesis in rat liver and oesophagus. J Cell Biochem 1994 56 : 449 54.
11. Hosaka S, Kawa S, Aoki Y, Tanaka E, Yoshizawa K, Karasawa Y et al. Hepatocarcinogenesis inhibition by caffeine in ACI rats treated with 2-acetylaminofluorene. Food Chem Toxicol 2001 39 : 557 61.
12. Kim SH, Lee CS. The effect of caffeine on diethylnitrosamine-initiated hepatic altered foci in a mid-term induction system. In Vivo 1992 6 : 223 6.
13. Okano J, Nagahara T, Matsumoto K, Murawaki Y. The growth inhibition of liver cancer cells by paclitaxel and the involvement of extracellular signal-regulated kinase and apoptosis. Oncol Rep 2007 17 : 1195 200.
14. Feng FY, Varambally S, Tomlins SA, Chun PY, Lopez CA, Li X et al. Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity. Oncogene 2007 26 : 3431 9.
15. Winograd-Katz SE, Levitzki A. Cisplatin induces PKB/Akt activation and p38MAPK phosphorylation of the EGF receptor. Oncogene 2006 25 : 7381 90.
16. Gururajanna B, Al-Katib AA, Li YW, Aranha O, Vaitkevicius VK, Sarkar FH. Molecular effects of taxol and caffeine on pancreatic cancer cells. Int J Mol Med 1999 4 : 501 7.
17. 1 phase arrest in JB6 cells. Cancer Res 2004 64 : 3344 9.
18. He Z, Ma WY, Hashimoto T, Bode AM, Yang CS, Dong Z. Induction of apoptosis by caffeine is mediated by the p53, Bax, and caspase 3 pathways. Cancer Res 2003 63 : 4396 401.
19. Asaad NA, Zeng ZC, Guan J, Thacker J, Iliakis G. Homologous recombination as a potential target for caffeine radiosensitization in mammalian cells: reduced caffeine radiosensitization in XRCC2 and XRCC3 mutants. Oncogene 2000 19 : 5788 800.
20. Lelo A, Miners JO, Robson R, Birkett DJ. Assessment of caffeine exposure: caffeine content of beverages, caffeine intake, and plasma concentrations of methylxanthines. Clin Pharmacol Ther 1986 39 : 54 9.
21. Jang MH, Shin MC, Kang IS, Baik HH, Cho YH, Chu JP et al. Caffeine induces apoptosis in human neuroblastoma cell line SK-N-MC. J Korean Med Sci 2002 17 : 674 8.
22. Matsumoto K, Okano J, Nagahara T, Murawaki Y. Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition. Int J Oncol 2006 29 : 1501 8.
23. Okano J, Matsumoto K, Nagahara T, Murawaki Y. Gefitinib and the modulation of the signaling pathways downstream of epidermal growth factor receptor in human liver cancer cells. J Gastroenterol 2006 41 : 166 76.
24. Berasain C, Castillo J, Prieto J, Avila MA. New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system. Liver Int 2007 27 : 174 85.
25. Vantaggiato C, Formentini I, Bondanza A, Bonini C, Naldini L, Brambilla R. ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. J Biol 2006 5 : 14.
26. Frey MR, Dise RS, Edelblum KL, Polk DB. p38 Kinase regulates epidermal growth factor receptor downregulation and cellular migration. EMBO J 2006 25 : 5683 92.
27. Zhang W, Gordon M, Lenz HJ. Novel approaches to treatment of advanced colorectal cancer with anti-EGFR monoclonal antibodies. Ann Med 2006 38 : 545 51.